Delivery Order SPE2DB24D2101-SPE2DB26FKFBM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 3, 2025, with completion expected by September 4, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $7,146.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for ACT-O-VIALS pharmaceutical supplies, with completion targeted for April 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $14,404.40 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,949.28 to AmerisourceBergen Drug Corp for Act-O-Vials on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at approximately $24K to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for Act-O-Vials on July 29, 2025, with completion targeted for July 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger pharmaceutical supply contract with DLA. The award specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $6,860.20 to AmerisourceBergen Drug Corp for Act-O-Vials pharmaceutical products on September 17, 2025, with completion expected by September 18, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $6,693.29 to AmerisourceBergen Drug Corp for ACT-O-Vials on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of AmerisourceBergen's extensive portfolio of federal medical...
- The Defense Logistics Agency awarded a $21,606.60 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and reflects the company's role as a critical vendor for military...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB26FKFBMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,744.08 to AmerisourceBergen Drug Corp for ACT-O-VIALS on October 22, 2025, with completion scheduled for October 23, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and other government healthcare systems. The company's contract portfolio with DLA demonstrates extensive capability in supplying pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for ACT-O-VIALS represents a specific pharmaceutical supply requirement within the broader framework of DLA's Medical Supply Chain, supporting military healthcare programs and other government healthcare systems. The firm fixed-price structure and rapid completion timeline reflect the time-sensitive nature of pharmaceutical supply deliveries to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/22/25 |